Conditions: Cancer
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 338
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the long term tolerability and safety of dalteparin in subjects with cancer.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: dalteparin
Intervention descriptions: intervention 1: Daily subcutaneous injection 200IU/kg dalteparin

Protocol document: